Market Research Logo

Pulmonary Drug Delivery Devices Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

Pulmonary Drug Delivery Devices Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

The report on global pulmonary drug delivery devices market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global pulmonary drug delivery devices market to grow with a CAGR of 6.0% over the forecast period of 2018-2024. The study on pulmonary drug delivery devices market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

A large number of populations are affected with respiratory disorders that include COPD, bronchitis, emphysema, interstitial lung diseases, tumors of the lung, pulmonary embolism, asthma and related disorders. Pulmonary asthma and cystic fibrosis are the most common form of lungs disorders found among the global population. Thus increasing presence of large patient pool with respiratory disorder is expected to fuel the pulmonary drug delivery devices market. Besides this, increasing technological developments in the form of smart/digital inhalers, increasing number of smokers, and growth of the distribution network will also drive the demand for the pulmonary drug devices. However lengthy product approvals and issues pertaining to the stability of the drugs are some of the hiccups hindering the market growth. Introduction of metered dose inhalers that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine can create huge growth opportunities in near future

The global pulmonary drug delivery devices market has been dominated by the North America region over the historic period 2016 followed by Europe. Increasing number of patients affected with lungs disorder coupled with developed healthcare infrastructure are the key factors responsible for driving the growth of pulmonary drug delivery devices market in this region. Also rising geriatric population in the U.S to augment the growth of the market in this region. Asia Pacific region is expected to be the fastest growing region on account of developing healthcare infrastructure , increased spending on healthcare in developing countries like India, China and other south East Asian countries.

Asia Pacific region is expected to be the fastest growing region on account of developing healthcare infrastructure , increased spending on healthcare in developing countries like India, China and other south East Asian countries.

The report on pulmonary drug delivery devices market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pulmonary drug delivery devices market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global pulmonary drug delivery devices market over the period of 2016 to 2024. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global pulmonary drug delivery devices market is segmented on the basis of product type, application and distribution channel.

Global Pulmonary Drug Delivery Devices Market by Product Type
Metered Dose Inhaler
Dry Powder Inhaler
Nebuliser
Global Pulmonary Drug Delivery Devices Market by Application
Asthma
COPD
Cystic Fibrosis
Others
Global Pulmonary Drug Delivery Devices Market by Distribution Channel
Hospital Pharmacies
Retail Pharmacy Stores
Others

Company Profiles
Teva Pharmaceutical Industries Ltd
AstraZeneca Plc
GlaxoSmithkline Plc
Boehringer Ingelheim GmbH
Merck & Co., Inc.
Novartis AG
Omron Corporation
Sunovion Pharmaceuticals Inc.
GF Health Products, Inc.
3M Healthcare

How this report delivers?
1. Comprehensive analysis of global as well as regional markets of pulmonary drug delivery devices market.
2. Complete coverage of all the segments in pulmonary drug delivery devices market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global pulmonary drug delivery devices market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on pulmonary drug delivery devices market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pulmonary drug delivery devices market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

Company Profiles
Teva Pharmaceutical Industries Ltd
AstraZeneca Plc
GlaxoSmithkline Plc
Boehringer Ingelheim GmbH
Merck & Co., Inc.
Novartis AG
Omron Corporation
Sunovion Pharmaceuticals Inc.
GF Health Products, Inc.
3M Healthcare

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report